| Smooth muscle cells contribute the majority of foam cells in ApoE (Apolipoprotein E)-deficient mouse atherosclerosis Y Wang, JA Dubland, S Allahverdian, E Asonye, B Sahin, JE Jaw, DD Sin, ... Arteriosclerosis, thrombosis, and vascular biology 39 (5), 876-887, 2019 | 283 | 2019 |
| Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism JA Dubland, GA Francis Frontiers in cell and developmental biology 3, 3, 2015 | 148 | 2015 |
| Serum-protein interactions with anticancer Ru (III) complexes KP1019 and KP418 characterized by EPR N Cetinbas, MI Webb, JA Dubland, CJ Walsby JBIC Journal of Biological Inorganic Chemistry 15, 131-145, 2010 | 114 | 2010 |
| So much cholesterol: the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation JA Dubland, GA Francis Current opinion in lipidology 27 (2), 155-161, 2016 | 88 | 2016 |
| Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD A Levin, M Tang, T Perry, N Zalunardo, M Beaulieu, JA Dubland, K Zerr, ... Clinical Journal of the American Society of Nephrology 12 (9), 1447-1460, 2017 | 85 | 2017 |
| Carbon–carbon bond-forming reactions of α-carbonyl carbocations: exploration of a reversed-polarity equivalent of enolate chemistry PS Lai, JA Dubland, MG Sarwar, MG Chudzinski, MS Taylor Tetrahedron 67 (39), 7586-7592, 2011 | 64 | 2011 |
| Pathways of smooth muscle foam cell formation in atherosclerosis CS Pryma, C Ortega, JA Dubland, GA Francis Current Opinion in Lipidology 30 (2), 117-124, 2019 | 63 | 2019 |
| Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid–liquid extraction method for the ABSCIEX API-5000 mass spectrometry system JG Van Der Gugten, J Dubland, HF Liu, A Wang, C Joseph, DT Holmes Journal of clinical pathology 65 (5), 457-462, 2012 | 61 | 2012 |
| Low LAL (lysosomal acid lipase) expression by smooth muscle cells relative to macrophages as a mechanism for arterial foam cell formation JA Dubland, S Allahverdian, KJ Besler, C Ortega, Y Wang, CS Pryma, ... Arteriosclerosis, thrombosis, and vascular biology 41 (6), e354-e368, 2021 | 35 | 2021 |
| LAL (lysosomal acid lipase) promotes reverse cholesterol transport in vitro and in vivo KL Bowden, JA Dubland, T Chan, YH Xu, GA Grabowski, H Du, ... Arteriosclerosis, thrombosis, and vascular biology 38 (5), 1191-1201, 2018 | 27 | 2018 |
| Lamivudine, entecavir, or tenofovir treatment of hepatitis B infection: effects on calcium, phosphate, FGF23 and indicators of bone metabolism R Saeedi, A Mojebi-Mogharar, SK Sandhu, JA Dubland, JA Ford, ... Annals of hepatology 16 (2), 207-214, 2017 | 18 | 2017 |
| Lipid analysis by ion mobility spectrometry combined with mass spectrometry: A brief update with a perspective on applications in the clinical laboratory JA Dubland Journal of Mass Spectrometry and Advances in the Clinical lab 23, 7-13, 2022 | 12 | 2022 |
| Interference of ketone bodies on laboratory creatinine measurement in children with DKA: a call for change in testing practices D Feldman-Kiss, D Li, R Cleve, G Sinclair, JA Dubland, L Wang Pediatric Nephrology, 1-7, 2022 | 9 | 2022 |
| Analysis of 2-methylcitric acid, methylmalonic acid, and total homocysteine in dried blood spots by LC-MS/MS for application in the newborn screening laboratory: a dual … JA Dubland, B Rakić, H Vallance, G Sinclair Journal of Mass Spectrometry and Advances in the Clinical lab 20, 1-10, 2021 | 9 | 2021 |
| Erh Jaw J, Sin DD, Seidman MA, Leeper NJ, Francis GA. Smooth muscle cells contribute the majority of foam cells in ApoE (Apolipoprotein E)-deficient mouse atherosclerosis Y Wang, JA Dubland, S Allahverdian, E Asonye, B Sahin Arterioscler Thromb Vasc Biol 39, 876-887, 2019 | 7 | 2019 |
| Editorial commentary: Role of inflammatory cytokines in genesis and treatment of atherosclerosis. Looking at foam cells through a different lens JA Dubland Trends in cardiovascular medicine 32 (3), 143-145, 2022 | 2 | 2022 |
| Effect on lipids and reverse cholesterol transport of switching to unboosted atazanavir vs remaining on ritonavir-boosted atazanavir in regimens with a tenofovir backbone M Harris, R Saeedi, B Ganase, M Yousefi, J Dubland, GA Francis, ... Antiviral Therapy 19, A5-A6, 2014 | 1 | 2014 |
| Mass Spectrometry-Based Metabolomics for the Clinical Laboratory JA Dubland Clinical Metabolomics Applications in Genetic Diseases, 17-42, 2023 | | 2023 |
| A simple method modification to increase separation of 2-and 3-hydroxyglutaric acid by GC–MS for clinical urine organic acids analysis JA Dubland, G Sinclair, H Vallance, B Rakić Clinical Biochemistry 105, 81-86, 2022 | | 2022 |
| Advances in Ion Mobility Spectrometry E te Brinke, JA Dubland, SP Neal, KM Szykuła, F Weiss Advances in Ion Mobility Spectrometry, 237, 2022 | | 2022 |
